D. Piscitelli

The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.

L. Lesko, L. Augsburger, D. Piscitelli, 1998, Pharmaceutical development and technology.

Alternative Forms and Functions of the c-kit Receptor and Its Ligand During Spermatogenesis

M. Giorgio, D. Piscitelli, P. Rossi, 1996 .

Identification of 3',5'-cyclic adenosine monophosphate-inducible nuclear factors binding to the human urokinase promoter in mouse Sertoli cells.

D. Piscitelli, P. Rossi, R. Geremia, 1993, Molecular endocrinology.

Identification of 3',5'-cyclic adenosine monophosphate-inducible nuclear factors binding to the human urokinase promoter in mouse Sertoli cells.

D. Piscitelli, P. Rossi, R. Geremia, 1993, Molecular endocrinology.

Biological characterization of recombinant human follicle stimulating hormone isoforms.

D. Piscitelli, M. Mascia, R. Papoian, 1999, Human reproduction.

Setting dissolution specifications for modified-release dosage forms.

D. Piscitelli, D. Young, Deborah A. Piscitelli, 1997, Advances in experimental medicine and biology.

Purification and characterization of a low-Km 3':5'-cyclic adenosine phosphodiesterase from post-meiotic male mouse germ cells.

M. Giorgi, D. Piscitelli, P. Rossi, 1992, Biochimica et biophysica acta.

Nonlinear in vitro-in vivo correlations.

J Devane, D Young, D. Piscitelli, 1997, Advances in experimental medicine and biology.